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Abstract
Pediatric	origin	of	cancer	stem	cell	hypothesis	holds	
great	promise	and	potential	in	adult	cancer	treatment,	
however;	 the	 road	 to	 innovation	 is	 full	of	obstacles	
as	 there	 are	 plenty	 of	 questions	 left	 unanswered.	
First,	the	key	question	is	to	characterize	the	nature	of	
such	stem	cells	 (concept).	Second,	 the	quantitative	
imaging	of	pediatric	stem	cells	should	be	implemented	
(technology).	Conceptually,	pediatric	stem	cell	origins	
of	adult	cancer	are	based	on	the	notion	that	plasticity	
in	 early	 life	 developmental	 programming	 evolves	
local	environments	 to	cancer.	Technologically,	 such	
imaging	in	children	is	lacking	as	all	imaging	is	designed	
for	 adult	 patients.	We	postulate	 that	 the	need	 for	
quantitative	 imaging	to	measure	space-time	changes	
of	plasticity	 in	early	 life	developmental	programming	
in	children	may	trigger	 research	and	development	of	
the	 imaging	technology.	Such	quantitative	 imaging	of	
pediatric	origin	of	adulthood	cancer	will	help	develop	
a	 spatiotemporal	monitoring	 system	 to	 determine	
cancer	 initiation	and	progression.	Clinical	validation	of	
such	speculative	hypothesis-that	cancer	originates	in	a	
pediatric	environment-will	help	 implement	a	wait-and-
watch	strategy	for	cancer	treatment.
Key words:	Pediatric	origins	of	adult	cancer;	Imaging	of	
single	cells
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Core tip:	How	does	“spatiotemporal	tracking	of	cancer	
stem	cells”	 should	be	achieved	 in	an	organism	 for	
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pediatric	origins	of	adult	cancer?	Improving	the	resolution	
of	current	 imaging	technologies	down	to	the	single	cell	
level	 is	 essential.	However,	 how	 single	 cells	 could	
be	 tracked	 label-free	 throughout	 the	 lifetime	of	 a	
human	body	will	be	challenging.	Such	technologies,	 if	
developed,	can	potentially	provide	an	evidence	base	for	
cancer	prevention	and	treatment.
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INTRODUCTION
In the United States, cancer affected more than 1.4 
million individuals in 2007, with a treatment cost over 
$206 billion, about 33% of the aggregate medical 
services of $686 billion (the National Cancer Institute)[1]. 
Much progress has been made in defining the genetic 
mutations, known as the hallmarks of cancer[2] and in 
revealing the biological principles of metastasis[3], but 
this has not been effectively translated into significant 
benefits to patients. “Cancer genomic research 
has come to a crossroads with the realization that 
intratumoral spatial and temporal heterogeneity is a 
confounding factor”[4]. The discovery of this intratumoral 
spatiotemporal heterogeneity drives our understanding 
of epigenetics, which in turn defines the role of the 
environment[5], including chemical factors, cellular[6], 
and physical factors like tissue elasticity[7]. Managing 
tumor microenvironment may offer a holistic regimen 
for cancer patients with better ratio of benefit over 
risks[8]. These imply current cancer treatment do not 
address the root of cancer initiation and progression. 
New strategies are desperately needed. 
MUTATION-TARGETED THERAPY FAILS 
IN CLINIC
As many mutated gene targeting drugs fail clinically, 
including mutation-targeted kinase inhibitors (bosutinib, 
ibrutinib, and cabozantinib) for glioblastoma (GBM)[9], 
multi-anti-HER2 targeted drugs(trastuzumab, lapatinib 
and/or T-DM1) for breast cancer[10], HSP70[11] and drugs 
through the regulation of mutant p53 and TAp63 in 
p53-mutated pancreatic cancer cells[12], we realize that 
not only the genetic mutations, but also the epigenetic 
changes (the role of the environment), shape cancer 
initiation and progression, in some cases, which may 
likely initiate in fetus development. Data from fetal 
exposome indicates that “utero exposures link to 
childhood cancer risk, and advances in epigenomics 
help understanding the effects of biological phenomena, 
environmental stressors, environmental and lifestyle 
factors on eliciting changes in the epigenome, leading 
to cancer initiation and progression”[13]. These data 
showing mutated gene targeting drugs alone fail in 
clinic demands a new concept for cancer initiation and 
progression, thereby improving treatment paradigm. 
Combining targeted and nontargeted therapy potentially 
leads to a paradigm shift from current targeted treatment 
of cancer.
PEDIATRIC AND ADOLESCENT PATIENTS 
RESPOND TO CANCER TREATMENT 
DIFFERENTLY FROM ADULT PATIENTS
Pediatric and adolescent patients have been speculated 
to respond to cancer treatment differently from those 
adult patients; however, lack of clinical trials on this 
population of patients led to inconclusive data sets thus 
far. For example, clinical trials “designed to determine 
the maximum tolerated dose of chemotherapies” 
(https://clinicaltrials.gov/ct2/show/NCT00993044?co
nd=pediatric+origins+of+cancer&rank=1, accessed 
August 31, 2017) by Children’s Hospital Los Angeles 
conducted in 2009 “a phase Ⅰ study of vincristine, 
escalating doses of irinotecan, temozolomide and 
bevacizumab (Vit-b) in pediatric and adolescent 
patients with recurrent or refractory solid tumors of 
non-hematopoietic origin” (ClinicalTrials.gov Identifier: 
NCT00993044) without conclusion as it recruited on 
12 patients. The primary objective of this study is “to 
evaluate the efficacy of moxetumomab pasudotox 
in pediatric participants with relapsed or refractory 
B-cell acute lymphoblastic leukemia (ALL) or B-cell 
lymphoblastic lymphoma” (The study was terminated 
prior to a planned interim analysis based on “lack of 
required efficacy in the first 32 participants enrolled”, 
sponsor: MedImmune LLC) (ClinicalTrials.gov Identifier: 
NCT02227108, first received: August 21, 2014). 
Pediatricians demand for children-specific clinical trials 
to gain better efficacies. 
HYPOTHESIS OF PEDIATRIC ORIGINS OF 
ADULT CANCER
As environment-derived epigenetic changes affect stem 
cell initiating development, most likely it occurs in early 
embryonic and fetus development. Dr. David Barker 
first observed that “low birth weight (LBW) is associated 
with chronic diseases”[14], such as coronary artery 
disease (CAD)[15], Type Ⅱ diabetes mellitus (T2DM), 
cancer (breast), osteoporosis and various psychiatric 
conditions, which led him to conceptualize “fetal origins 
of adult disease” (FOAD)[16], a.k.a., “pediatric origin 
of adulthood diseases” (POAD), or “developmental 
and environmental origins of adult disease” (DEOAD). 
POAD is based on the notion that, plasticity in early life 
developmental programming evolves local environments 
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to increase survival and reproduction[17]. The period for 
developmental plasticity extends from preconception to 
early childhood, which involves epigenetic modifications 
in response to environmental changes, and exerts the 
effects during life history phase transitions[18]. However, 
little is known about life history phase transitions 
responding to specific environmental cues.
One way of deciphering life history phase transitions 
for POAD would be to map out all the cells and their 
descendants throughout a lifetime using quantitative 
imaging technologies. The term stem cell originated 
in the context of embryological development by 
German biologist Ernst Haeckel in 1868 to describe 
the ancestor unicellular organism from which he 
presumed all multicellular organisms evolved[19]. Such 
“a prototypical cancer stem cell is a distinct cell in the 
embryo, responsible for giving rise to cancer found 
later in adulthood.” In 1953-Leroy Stevens discovered 
“teratomas that contained mixtures of differentiated 
and undifferentiated cells, including hair, bone, intestinal 
and blood tissue.” This implies the embryonic origin 
of tumor. Capable of tracing origin of cancer to cancer 
stem cells (cancer initiating cells), researchers can 
develop an innovative approach to treat the root of 
cancer. POAD in cancer takes on a new concept as 
cancers are being redefined as “common chronic and 
aging disorders” instead of “invading aliens,” implying 
human beings may need to co-exist with cancer[20]. 
Indeed, cancer genomics reveals that genetic mutations 
exist in a wide range of human tumors as shown with 
different techniques[21], including detection of CX43 
mutations in leukemia with microfluidic device[22]; thus, 
we need to reassess current mutation-target therapy, 
in particular current pharmaceutical strategies, focusing 
on multiple mutation targets, largely limited to small 
molecule blockade of gain-of-function mutations in 
accessible subcellular localizations, which to date, 
have not yet proven to be very effective. There is still 
“much to be learned about optimizing tumor responses, 
managing side effects, and minimizing the significant 
stochastic risk of drug resistance that is still too high”[23]. 
Mounting literature on tissue microenvironments and cell 
differentiation, which likely signal cancer initiation and 
progression, argues against a role for acquired cancer 
gene mutations as a critical event in tumorigenesis, such 
as “genetic mutations associated with metastatic clear cell 
renal cell carcinoma”[24,25]. This has caused “a waning of 
excitement regarding the direction of molecular oncology 
because of the large number of candidate cancer genes 
combined with detection of genetic heterogeneity 
within tumor subclones”[26]. The influence of host tissue 
microenvironment and cell differentiation and the role 
of acquired somatic mutations in tumorigenesis are 
not mutually exclusive, but being intertwined, thereby 
demanding integrated management of cancer to avoid 
activating dormant tumor subclones so as to maintain 
tumor dormancy[20]. Spatiotemporal monitoring of fetal 
subclonal programming engenders potential applications 
in diagnosis, preventive and curative measures for adult 
diseases. Such strategies include the development of 
novel preventive measures that are predicated on diet 
(tissue remodeling, metabolism changes)[27], life style 
(diet)[28], behavior (exercise)[29], stress, and medical 
care. Quantitative imaging of spatiotemporal biomarker 
expression would help define certain therapeutic 
windows-time-to-treatment-for pediatric origins of 
adulthood cancer, allowing clinicians perhaps to adopt a 
watch-and-wait strategy for prevention-based strategy 
for some predicted cancers.
EVIDENCE TO SUPPORT THE 
HYPOTHESIS
Stem cell origin of cancer emerges as a leading force 
in cancer diagnostics and treatment; however, little is 
known about the pediatric origin of adult cancer (POAC). 
Here, we will focus on POAC.
Stem cell origin of cancer consists of two conceptual 
schools of mechanism of tumorigenesis: “reserve-
born-with-preexisted stem cells” and “bone fide locally-
produced stem cells”-both involve with stem cell 
developmental biology. The “reserve-born-with-pre-
existed” concept involves “a cancer stem cell originating 
in the early development, which seeds in waiting for 
the right soil (spatial) and the temporal (switching 
signal) that contribute towards cancer.” The “bone fide 
locally-produced stem cell” are derived from undergoing 
genetic modifications leading to dedifferentiation, a 
process triggered by spatiotemporal signaling molecules 
such as persistent inflammation. Neither of these two 
conceptually defined stem cells can be identified in 
vivo with current technologies (we cannot detect a 
single cell in vivo); thus, the identity of these stem 
cells remains controversial. Lineage tracing shows that 
“Lgr5-expressing chief cells recruited to function as 
stem cells to affect epithelial renewal following injury 
by activating Wnt signaling, thus acting for maintaining 
the homeostatic stem cell pool, while Lgr5+ chief cells 
act as a major cell-of-origin of gastric cancer in a non-
variegated Lgr5-2A-CreERT2 mouse model”[30]. Clearly, 
the hypothesis of “cancer is to embryology as mutation 
is to genetics” postulates cancer as embryological 
phenomenon as reactivated in an entirely inappropriate 
context[31], thereby indicating a new approach to cancer-
searching for such “inappropriate context” in stem cell 
development. 
It has been puzzled to observe that some tissue 
types give rise to human cancers more often than other 
tissue types. It is interesting to find that “the lifetime 
risk of cancers of diverse types is strongly correlated 
(0.81) with the total number of divisions of the normal 
self-renewing cells (stem cells) maintaining that tissue's 
homeostasis”[32]. The tissue’s homeostasis is regulated 
by environmental factors or inherited predispositions. 
Such “correlation between the incidence of cancers and 
the number of stem-cell divisions in the corresponding 
Li	SW	et	al .	Pediatric	origins	of	adulthood	cancer
18 February 26, 2018|Volume 10|Issue 2|WJSC|www.wjgnet.com
normal tissues”[33] shed new light on how cancer initiates 
and progression. 
The tissue-specific cancer risk (environmental factors) 
can regulate the lifetime number of tissue-specific 
stem-cell divisions[34], suggesting that “intrinsic risk 
factors contribute only modestly (less than 10%-30% 
of lifetime risk) to cancer development, based on that 
the rates of endogenous mutation accumulation by 
intrinsic processes are not sufficient to account for the 
observed cancer risks.” “Concomitant activation of the 
Wnt pathway and suppression of Mapk signaling by 
two small molecule inhibitors (2i) in the presence of 
leukaemia inhibitory factor (LIF) (hereafter termed 2i/L) 
induces a naive state in mouse embryonic stem (ES) 
cells, indicating the epigenetic and genomic integrity is 
required for developmental potential of embryonic stem 
cells”[35]. All above data shows that cancer risk is heavily 
influenced by extrinsic factors. These signal transduction 
management is supported by the female ES cells that 
display 2i/L-ES-cell-like transcriptional signatures while 
preserving gamete-derived DNA methylation and 
autonomous developmental potential[36]. 
Increased lines of evidence show “inappropriate 
context” (i.e., environment) in stem cell development 
may contribute to cancer development through their 
interactions with abnormal environmental elements such 
as inflammation. We pointed out that the crosstalk for 
tumorigenesis may have a critical stage characterized 
as a “therapeutic window”, which can be identified by 
association of molecular, biochemical and biological 
events in the converge developmental stages of different 
types of stem cells [e.g., normal stem cells (NSC), CSC 
and embryonic stem cells][37]. Such convergence of 
NSC and CSC demands spatiotemporal confinement of 
boundary for breaching to malignancy in response to 
stress (tissue injury/wound healing). Stress-responsive 
transcription factor levels rise to reach excess, thereby 
causing stem cell lineage commanders to cancer[38]. It 
is challenging to distinguish NSC and CSC as both share 
common features. 
POAC DEMANDS FOR DEVELOPMENT 
OF INNOVATIVE DETECTION 
TECHNOLOGIES
Safety is the most important for POAC detection tech-
nologies, as pediatric development plays a critical 
role in adult life, including cognitive capacity, physical 
and physiological functions. In practice, the neglect of 
pediatric origin of adult diseases desperately calls for 
innovative concepts and technologies to be developed. 
The Chinese proverb state that from the health of 
three-year-old body, you can predict the health care 
needed for an 80-year-old - from seven-year-old to see 
a lifetime health situation-which makes sense based 
on the pediatric (fetal, childhood) origin of adulthood 
diseases. As the cost of human genome sequencing 
reaches $1000[39] or even $100, physicians can know 
human genome so well that genomics will play a vital 
role in the future – thereby mapping out each step 
molecular profiles in a lifetime. Quantitative imaging is 
needed to define “therapeutic windows”[40] with predictive 
values for single cells based on life style measurement 
and biomarker profiles, with suitable criteria robust 
enough to determine therapeutic intervention. A 
biological global positioning system (bGPS)[41] could be 
considered for tracking spatiotemporal cancer stem cell 
behaviors throughout the body. Quantitative imaging is 
expected to improve to the point where it is sufficiently 
sensitive to detect subclonal growth and progression 
on the single-cell level[20]. Quantitative imaging may 
include genetic-tagged labeling and non-genetic-tagged 
labeling, presumably for a lifetime and at the single cell 
level[41]. Ideal imaging would be label-free, not invasive 
or minimally invasive. Such technologies might include 
“Raman spectroscopy for spontaneous and coherent 
Raman scattering microscopic imaging in the context 
of single cells, laser tweezers, tissue sections, biopsies 
and condensing Raman spectrum for a single-cell 
phenotype analysis”[42,43], as currently used for defining 
nasopharyngeal carcinoma[44]. Raman profiling for the 
single-cell analysis requires establish Raman spectra 
of individual cells by using filtering methodologies for 
pre-processing of Raman spectra signature, allowing 
to distinguish and feature as Raman-based biomarkers 
for single-cells with capture of spatial and temporal 
changes.
Big data based on supercomputing, such as the 
team led by University of Washington’s David Baker 
in collaboration with researchers at the United States 
Department of Energy Joint Genome Institute (DOE 
JGI), can lead to an integrated comprehensive approach 
to cancer. Part of this integration is a lifetime imaging 
system that can define the convergence of normal 
stem cell and cancer stem cell developmental stages 
to determine appropriate therapies and assess their 
effects[37], for example, in monitoring maintenance 
immunotherapy[45]. Spatiotemporal monitoring of single 
cells will be high demand in the future because cancer 
originates from a single cell. The hypothesis of origin 
of a functional single cell has gained attention through 
time, including the Nobel Prize committee. For example, 
the 2014 Nobel Prize in Physiology or Medicine was 
awarded to John O'Keefe, May-Britt Moser and Edvard 
Ⅰ. Moser for their discovery that neurons in the brain 
are firing in response to the positioning of the body in 
a known space, which is referred to as the biological 
positioning system. This finding implies on a single-
cell origin of a biological function or a single cell origin 
of an organ. Currently, “cancer stem cell” and the cell 
of origin for a tumor are not necessarily the same, as 
these terms have not been used carefully throughout 
the literature. Publications frequently flip back and forth 
between normal stem cells and cancer stem cells, and 
it is often unclear whether they refer to a normal or 
transformed stem cell when referring to “stem cell”. It is 
still in debate whether cancer exists as cancer stem cells 
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or cancer is through de-differentiation of an adult cell, 
as in colon cancer[46]. Tracking down the cancer-initiating 
cell (CIC) subset of human colon cancers helped identify 
“nicotinamide phosphoribosil transferase (NAMPT) as 
a novel therapeutic target in colon cancer progression 
and relapse”[47,48], suggesting a possible solution to the 
puzzle. All these imply “the single-cell origin of cancer 
in colon cancer, which is supported for clonal origins 
of synchronous multifocal tumors in the hepatobiliary 
and pancreatic system”[49] and in the same subclone of 
cells of colorectal cancer[50]. Another report shows the 
patterns of glioma cell of origin, as somatic Nf1 loss 
in CD133+ neural progenitor/stem cells during late 
embryogenesis results in optic gliomas at three months 
of age, demonstrating that the cell of origin dictates the 
time to tumorigenesis[7], which can expose a break time 
or a “therapeutic window” of cancer progression[40].
Thus, the long-term advantage of imaging the single-
cell and monitoring the origin of cancer for staging cancer 
initiation and progression as well as utility of promising 
advances in immunotherapy remains to be seen in clinical 
trials on patients with malignancy. This FOAD concept, 
historically, was started with poor nutrition, and the “fetus 
adapts to survive but the ramifications of the FOAD 
extend beyond low birth weight (LBW) to responses to 
stressors later in life, resulting in various diseases[51]”. 
In 2017, a population-based cohort study of families in 
Suihua, China, shows that “prenatal exposure to famine 
led to the development of hyperglycemia and type 2 
diabetes in adulthood across consecutive generations[52]”. 
The cohort study consisted of 1034 families - 2068 
parents [parental generation (F1)] and 1183 offspring 
[offspring generation (F2)] – both F1 and F2 were 
affected by the Chinese Famine of 1959-1961. The found 
that, “Prenatal exposure to famine was associated with 
elevated risks of hyperglycemia (multivariable-adjusted 
OR: 1.93; 95%CI: 1.51, 2.48) and T2D (OR: 1.75; 
95%CI: 1.20, 2.54) in adulthood in F1. Furthermore, 
compared with the offspring of nonexposed parents, 
the F2 with exposed parents- especially both exposed 
parents-had increased hyperglycemia risk (OR: 2.02; 
95%CI: 1.12, 3.66) in adulthood.” However, neither did 
they predict nor they could track the disease progression, 
so they could not come up with prevention and treatment 
ahead of incidences of disease. They did one-time 
point blood testing, not sufficient to trace the disease. 
By improving understanding of FOAD or/and POAD, 
therefore, healthcare experts can prescribe preventive 
measures and treatment for those at higher risk, by 
using precise quantitative spatiotemporal imaging. Such 
imaging will guide how one could manipulate stem cell 
developmental programs for therapeutic use through 
time and space of single-cell in stem cell development.
Another challenge is how many single cells (i.e., 
the critical mass) should be analyzed for the clinical 
manifestation, in which treatment must be applied. How 
do we know a dormant subclone of cancer switches to 
a dominating subclone? How many single cells in such a 
dormant subclone or a dominating subclone can manifest 
in its clinical phenotype? A recent study shows that 
integrating 14226 single-cell RNA sequencing (scRNA-
seq) profiles from 16 patient samples with bulk RNA-
sequence profiles from 165 patient samples[53] into 
the body physiology[54,55], can reveal a comprehensive 
strategy of cancer prevention and treatment. Such com-
prehensive strategy is based on the tissue organization 
field theory (TOFT) on tumor initiation and develop-
ment[56]. Studying the POAC process through single cell 
imaging may likely help map out TOFT-evolved changes 
within an organism during development. In fact, the 
tissue organization field is reorganized through time 
and environmental factors such as dietary and lifestyle, 
a concept that has been speculated and yet to be 
elucidated. For example, “evaluation of sociodemographic 
and health data collected from 2310922 (2.3 million) 
16-19-year-old Jewish Israeli adolescents (mean 
age 17.3 ± 0.4, 59.5% male) shows that adolescent 
risk factors (e.g., Body mass index) for developing 
acute myeloid leukemia (AML) corelate that higher 
BMI in adolescence with the higher AML incidence in 
adulthood in this multiethnic population”[57]. The possible 
mechanism for this impact may be through a “hotspot 
for pre-neoplastic metaplasia and malignancy” in a 
transitional zone (TOFT) between diverse types of cells[58]. 
Multiple models and lineage trace imaging of single cells 
may therefore lead to show how this transitional zone 
serves as a source of malignancy for the transitional 
progenitor. Thus, controlling such transition may 
prevent cancer. Transitional zones can be assessed with 
“ultrasound shear wave elastography (US-SWE) in the 
normal prostate, which can be used to correlate with 
multiparametric magnetic resonance imaging (mpMRI) 
tissue characteristics, specifically quantitatively defining 
the peripheral zone (PZ) and the transitional zone 
(TZ) for prostate cancer”[59]. In the transitional zone, 
interactions between different cell types are essential for 
multiple biological processes, demanding concomitant 
multiple-single cell tracing techniques to be developed. 
A new report shows that “the labelling of ‘kiss-and-run’ 
interactions between immune cells ‘Labelling Immune 
Partnerships by SorTagging Intercellular Contacts’ 
(LIPSTIC)”, which captured the two-phase “interactions 
between dendritic cells and CD4+ T cells during T-cell 
priming in vivo”[60]. Phase #1, “an early, cognate 
stage, during which CD40–CD40L interactions occur 
specifically between T cells and antigen-loaded dendritic 
cells;” and phase #2, “non-cognate stage during which 
these interactions no longer require prior engagement 
of the T-cell receptor,” as shown in vivo in mouse 
models. Such a direct measurement of dynamic cell–
cell interactions is expected to use in clinical settings 
to observe pathological processes. For example, 
“integration of diffusion-weighted-magnetic resonance 
imaging with dynamic contrast-enhanced-magnetic 
resonance imaging for imaging biomarkers of response 
to treatment, can add predictive value of pathologic 
response to neoadjuvant therapy in breast cancer”[61]. 
Whether such imaging technologies can be adopt to 
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other cancer types remains to be elucidated. 
CONCLUSION
We attempt to address the nature of cells responsible 
for POAC, however; given the limitation of literature, 
many questions remain to be addressed, such as how 
to identify and target stem cells for POAC in infants or in 
fetus to trace the development at the single cell level? 
For example, will it be based on the cell surface marker, 
cell density, or certain transcriptional or translational 
features such as genetic mutations? Should the latter a 
case be, how one can distinguish such a cell from others 
without destroying tissue? Without such knowledge, it 
will be impossible to follow the development of a single 
stem cell even when the technical hurdle to image and 
monitor cells at the single cell level is resolved. We 
can predict that comprehensive artificial intelligence of 
medicine will lead to how “spatiotemporal tracking of 
cancer stem cells” should be achieved in an organism 
for pediatric origin of cancer. Supercomputing atlas of 
collecting big databases of cancer characteristics will 
offer a spatiotemporal tracking of all single cells in an 
organism throughout the lifetime of a human, thereby 
demonstrating a pediatric onset of adult cancer. Such 
advanced technologies, if developed, can potentially 
provide an evidence base for prevention and watch-
and-wait treatment of cancer.
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